These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 17197615)

  • 21. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the Combined First-Trimester Screen in High- and Low-Risk Patient Populations After Introduction of Noninvasive Prenatal Testing.
    Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
    J Ultrasound Med; 2015 Aug; 34(8):1423-8. PubMed ID: 26206828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal screening for chromosome abnormalities.
    Chitty L
    Br Med Bull; 1998; 54(4):839-56. PubMed ID: 10367418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Performance of different methods of estimating risk screening for chromosomal anomalies].
    Avătăjitei MC; Moscalu M; Martiniuc V; Onofriescu M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):515-22. PubMed ID: 23077946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
    Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
    Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antenatal screening for aneuploidy.
    Chitty LS
    Curr Opin Obstet Gynecol; 1998 Apr; 10(2):91-6. PubMed ID: 9551302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indications for Invasive Prenatal Testing before and after Noninvasive Prenatal Screening.
    Gill LA; Prosen TL
    Am J Perinatol; 2017 Sep; 34(11):1084-1087. PubMed ID: 28614867
    [No Abstract]   [Full Text] [Related]  

  • 28. Stepwise sequential aneuploidy screening in clinical practice.
    Wax JR; Cartin A; Smith D; Smith R; Chard R; Carpenter M; Pinette MG
    J Clin Ultrasound; 2012 Jan; 40(1):26-30. PubMed ID: 22102396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
    Benn P; Cuckle H; Pergament E
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First- and midtrimester Down syndrome screening and detection.
    Bahado-Singh RO; Choi SJ; Cheng CC
    Clin Perinatol; 2004 Dec; 31(4):677-94, v. PubMed ID: 15519423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACOG Practice Bulletin No. 27: Clinical Management Guidelines for Obstetrician-Gynecologists. Prenatal diagnosis of fetal chromosomal abnormalities.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2001 May; 97(5 Pt 1):suppl 1-12. PubMed ID: 11501567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Middle pregnancy ultrasound screening for fetal chromosomal diseases.
    Liu L; Zhou P; Cao Z; Tan X
    Mol Med Rep; 2017 Nov; 16(5):7641-7648. PubMed ID: 28944865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
    Shaw SW; Chen CP; Cheng PJ
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of second-trimester ultrasound in screening for Down syndrome.
    Cuckle H; Maymon R
    Ultrasound Obstet Gynecol; 2013 Mar; 41(3):241-4. PubMed ID: 23460191
    [No Abstract]   [Full Text] [Related]  

  • 36. The association between prenatal atrioventricular septal defects and chromosomal abnormalities.
    Morlando M; Bhide A; Familiari A; Khalil A; Morales-Roselló J; Papageorghiou AT; Carvalho JS
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():31-35. PubMed ID: 27888703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical practice. Prenatal screening for aneuploidy.
    Driscoll DA; Gross S
    N Engl J Med; 2009 Jun; 360(24):2556-62. PubMed ID: 19516035
    [No Abstract]   [Full Text] [Related]  

  • 39. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).
    Wald NJ; Rodeck C; Hackshaw AK; Walters J; Chitty L; Mackinson AM
    J Med Screen; 2003; 10(2):56-104. PubMed ID: 14746340
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of the second-trimester 'genetic sonogram' for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing.
    Odibo AO; Ghidini A
    Prenat Diagn; 2014 Jun; 34(6):511-7. PubMed ID: 24436177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.